ADAM21
Title: ADAM21: A Promising Target for Multiple Diseases
Description:
ADAM21 (A Disintegrin And Metalloproteinase 21) is a key regulator of cell-cell interactions known for its involvement in various cellular processes. It has garnered significant attention for its potential role in the development of numerous diseases, making it a promising therapeutic target.
Associated Diseases:
ADAM21 has been implicated in several diseases, including:
- Arthritis: It is overexpressed in synovial tissues of patients with rheumatoid arthritis and osteoarthritis.
- Cancer: It promotes tumor growth, invasion, and metastasis in various cancers, including breast cancer, lung cancer, and colon cancer.
- Cardiovascular disease: It contributes to the formation of atherosclerotic plaques, increasing the risk of heart attacks and strokes.
- Neurological disorders: It is involved in the development of Alzheimer‘s disease and multiple sclerosis.
Did you Know ?
ADAM21 expression is significantly upregulated in over 80% of breast cancer cases, indicating its potential as a biomarker and therapeutic target for this prevalent disease.
